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The fungal metabolite (+)-geodin [systematic name: (2R)-
methyl 5,7-dichloro-4-hydroxy-60-methoxy-6-methyl-3,40-dioxo-
spiro[benzofuran-2,10-cyclohexa-20,50-diene]-20-carboxylate],
C17H12Cl2O7, was isolated from Aspergillus terreus. The crystal
structure contains two independent molecules in the asym-
metric unit. Molecules denoted 1 interact through O—H  O
hydrogen bonds creating chains of molecules parallel to the
crystallographic 21 screw axis. Molecules denoted 2 interact
through an O  Cl halogen bond, also creating chains of
molecules parallel to the crystallographic 21 screw axis.
Molecules 1 and 2 interact through another O  Cl halogen
bond. The two molecules are similar but molecules 2 have a
slightly more planar cyclohexadiene ring than molecules 1.
The absolute structure of (+)-geodin has been unequivocally
assigned with the spiro centre having the R configuration in
both molecules. The structurally related (+)-griseofulvin has
an S configuration at the spiro centre, a difference of potential
biological and biosynthetic relevance.
Comment
(+)-Geodin, (I), was originally isolated from Aspergillus
terreus (Raistrick & Smith, 1936) and elucidation of its
structure was initiated (Clutterbuck et al., 1937; Calam et al.,
1939, 1947), eventually resulting in the correct relative struc-
ture (Barton & Scott, 1958). A number of biological activities
have been reported for (I), including antiviral (Takatsuki,
Suzuki et al., 1969; Takatsuki, Yamaguchi et al., 1969), anti-
microbial (Rinderknecht et al., 1947), enhancement of fibri-
nolytic activity (Shinohara et al., 2000) and stimulation of
glucose uptake for rat adipocytes (Sato et al., 2005). Further-
more, (I) is a subunit of the compound Sch 202596, an
antagonist of the galanin receptor subtype GALR1 (Chu et al.,
1997). In an effort to synthesize Sch 202596, the total synthesis
of racemic geodin was completed (Katoh et al., 2002; Katoh &
Ohmori, 2000). Geodin, (I), shares the same grisan backbone
as (+)-griseofulvin, (II), consisting of ring systems A, B and C,
as shown for (II) in the Scheme below (Grove et al., 1952).
Additionally, both compounds (I) and (II) are dextrorotatory
and this general similarity prompted our interest in (I) since
(II) has anticancer properties (Ho et al., 2001; Panda et al.,
2005). (I) was isolated from A. terreus and tested in our
cellular anticancer assay (Rebacz et al., 2007) but did not
exhibit any activity (data not shown).
(I) crystallizes with two independent molecules in the
asymmetric unit (Fig. 1). Although the two molecules are quite
similar, there are small differences in their geometries.
Cyclohexadienone ring C in (I) is almost planar, with an r.m.s.
deviation of the least-square planes of 0.045 and 0.016 A˚ for
molecules 1 and 2, respectively. The largest deviation from this
plane is 0.070 (2)/0.024 (2) A˚ found for atoms C12/C22. The
distances O15  O13/O25  O23 are 4.999 (3)/5.245 (4) A˚,
reflecting the fact that the C ring in (I) for molecule 2 is
slightly more planar than that of molecule 1. In comparison,
cyclohexenone ring C in griseofulvin, (II) (Puttaraja et al.,
1982), has a half-chair conformation, with atoms C2 and C60
on the opposite sides of the plane. This means that the
distance O5  O3 is only 4.06 A˚, i.e. much shorter than the
equivalents O15  O13 and O25  O23 in (I). The ester
groups in the two molecules in the asymmetric unit of (I) are
rotated 21.4 (5)/16.9 (4) with respect to the planes of the
respective cyclohexadienone rings so that atoms O17/O27 are
located more or less above the centre of the respective five-
membered ring with short interatomic O17  O11/O27  O21
distances of 2.916 (4)/2.954 (3) A˚. The five-membered B rings
in the two molecules in (I) are rotated 89.89 (9)/88.13 (10)
with respect to the C rings. They are almost planar, with an
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Figure 1
A perspective view of the two independent molecules of geodin, (I),
showing the atom-numbering scheme and with displacement ellipsoids
drawn at the 50% probability level.
r.m.s. deviation of the five atoms of 0.028/0.034 A˚ for both
molecules. However, atoms O11(O21) and C13(C23) are
below the plane and C12(C22) above the plane. In both
molecules, there is an intramolecular hydrogen bond from
atom O12/O22 to O13/O23 (see Table 2).
The crystal packing down the a axis is shown in Figs. 2 and 3,
with the view showing the different packing of molecules 1
(Fig. 3a) and 2 (Fig. 3b) down the c axis. Molecules 1 are
hydrogen bonded with a hydrogen bond from atom O12 to
atom O15 in a neighbouring molecule (see Table 2, and Figs. 2
and 3a). This creates a chain of molecules along the crystal-
lographic 21 screw axis. A similar hydrogen bond is not found
in molecules 2. They are tilted slightly and the distance
between atoms O22 and O25(x + 2, y + 12, z + 2) is
4.521 (4) A˚. There are, however, halogen bonds between
atoms O23 and Cl21 from neighbouring molecules (see
Table 1, and Figs. 2 and 3b) creating chains of molecules along
the crystallographic 21 screw axis. Furthermore, molecules of
type 2 are oriented so that the AB ring system stacks with the
C ring from the next molecule in the helix. Molecules 1 and 2
interact via halogen bonds between atoms O27 and Cl12 (see
Table 1).
To increase knowledge of the structure–activity relationship
of these related compounds (Rønnest et al., 2009) the absolute
structure of (I) presented here was determined using anom-
alous signal from all reflections (Flack, 1983). This showed an
R configuration at the spiro centre of both crystallographically
independent molecules. In contrast, for (II) the absolute
configuration was determined based on alcoholytic reactions
(MacMillan, 1959) and later verified by Brown & Sim (1963)
by crystal structure determination of a brominated derivative
using film data to be S at the spiro centre and R at atom C60.
This structural difference between (I) and (II) could poten-
tially contribute to the observed absence of anticancer activity
(Rebacz et al., 2007) for (I).
Based on enzymatic studies of the biosynthesis of geodin,
(I) (Fujii et al., 1983), the spirocyclization reaction joining the
organic compounds
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Figure 2
The molecular packing of (I), showing the hydrogen- and halogen-bond
architecture; the view direction is down [100]. Hydrogen and halogen
bonds are drawn as dashed lines. [Symmetry codes: (i)x + 1, y + 12,z + 2;
(ii) x, y  12, z + 1.]
Figure 3
Helical chains in (I), viewed in the [001] direction, showing (a) molecules
of type 1 and (b) molecules of type 2. [Symmetry codes: (i) x + 1, y + 12,z + 2; (ii) x, y  12, z + 1.]
B and C rings is believed to be catalysed by an enzyme of the
multicopper protein class. The same reaction in the griseo-
fulvin, (II), biosynthesis, on the other hand, is presumed to be
mediated by a cytochrome P450 enzyme. The latter assump-
tion is founded on the identification of the griseofulvin, (II),
biosynthesis gene cluster (Chooi et al., 2010). These observa-
tions could explain the different configuration of the spiro
centres of (I) and (II) since it is reasonable that enzymes of
different classes lead to a disparate outcome in a similar
reaction with comparable substrates.
Experimental
A. terreus [IBT 28226, culture collection at Department of Systems
Biology, Technical University of Denmark (Lyngby, Denmark)] was
cultured on 50 plates of yeast extract sucrose agar at 298 K for 7 d,
extracted with ethyl acetate (2 l) and then concentrated to afford
1.2 g of raw extract. The raw extract was dissolved in 10% H2O in
MeOH (50 ml) and the aqueous phase was extracted with heptane
(50 ml). The water content was increased to 50% by adding H2O
(40 ml) and the resulting mixture was shaken with CH2Cl2 (90 ml).
The CH2Cl2 phase was concentrated (0.86 g) and further purification
was performed on a Phenomenex Luna(2) HPLC column (250 
10 mm, 5 mm, C-18) using 5 ml min1 H2O/CH3CN (isocratic run at
50/50 for 15 min) as the mobile phase to yield (I) (11.6 mg as a yellow
oil). Geodin, (I), was crystallized using sitting-drop vapour diffusion,
the drop consisting of EtOAc–heptane (4:1 v/v) and the reservoir
containing heptane, to afford yellow crystals.
Crystal data
C17H12Cl2O7
Mr = 399.17
Monoclinic, P21
a = 8.9276 (3) A˚
b = 11.3625 (4) A˚
c = 16.5006 (6) A˚
 = 94.456 (1)
V = 1668.76 (10) A˚3
Z = 4
Mo K radiation
 = 0.43 mm1
T = 120 K
0.25  0.15  0.08 mm
Data collection
Bruker SMART platform CCD
diffractometer
Absorption correction: multi-scan
(SADABS; Bruker, 2000)
Tmin = 0.82, Tmax = 0.97
22828 measured reflections
8165 independent reflections
7496 reflections with I > 2(I)
Rint = 0.029
Refinement
R[F 2 > 2(F 2)] = 0.053
wR(F 2) = 0.145
S = 1.06
8165 reflections
480 parameters
1 restraint
H-atom parameters constrained
max = 0.81 e A˚
3
min = 0.36 e A˚3
Absolute structure: Flack (1983),
3819 Friedel pairs
Flack parameter: 0.04 (6)
H atoms were observed in a difference synthesis and subsequently
placed in idealized positions. They were refined using a riding model,
with aryl C—H = 0.95 A˚ and Uiso(H) = 1.2Ueq(C), methyl C—H =
0.98 A˚ and Uiso(H) = 1.5Ueq(C), and hydroxy O—H = 0.84 A˚ and
Uiso(H) = 1.2Ueq(O).
Data collection: SMART and SAINT (Bruker, 1998); cell refine-
ment: SMART and SAINT; data reduction: SMART and SAINT;
program(s) used to solve structure: SHELXS97 (Sheldrick, 2008);
program(s) used to refine structure: SHELXL97 (Sheldrick, 2008);
molecular graphics: ORTEP-3 (Farrugia, 1997) and Mercury (Macrae
et al., 2006); software used to prepare material for publication:
enCIFer (Allen et al., 2004).
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described at the back of the journal.
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